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Alternative splicing and polyadenylation of human cytomegalovirus (HCMV) immediate-early (IE)
pre-mRNAs are temporally regulated and rely on cellular RNA-processing factors. This study
examined the location and abundance of essential RNA-processing factors, which affect
alternative processing of UL37 IE pre-mRNAs, during HCMV infection. Serine/threonine protein
kinase 1 (SRPK1) phosphorylates serine/arginine-rich proteins, necessary for pre-spliceosome
commitment. It was found that HCMV infection progressively increased the abundance of
cytoplasmic SRPK1, which is regulated by subcellular partitioning. The essential polyadenylation
factor CstF-64 was similarly increased in abundance, albeit in the nucleus, proximal to and within
viral replication compartments (VRCs). In contrast, the location of polypyrimidine tract-binding
protein (PTB), known to adversely affect splicing of HCMV major IE RNAs, was temporally
regulated during infection. PTB co-localized with CstF-64 in the nucleus at IE times. By early
times, PTB was detected in punctate cytoplasmic sites of some infected cells. At late times, PTB
relocalized to the nucleus, where it was notably excluded from HCMV VRCs. Moreover, HCMV
infection induced the formation of nucleolar stress structures, fibrillarin-containing caps, in close
proximity to its VRCs. PTB exclusion from HCMV VRCs required HCMV DNA synthesis and/or
late gene expression, whereas the regulation of SRPK1 subcellular distribution did not. Taken
together, these results indicated that HCMV increasingly regulates the subcellular distribution and
abundance of essential RNA-processing factors, thereby altering their ability to affect the
processing of viral pre-mRNAs. These results further suggest that HCMV infection selectively
induces sorting of nucleolar and nucleoplasmic components.
INTRODUCTION
The human cytomegalovirus (HCMV) UL36–38 locus
produces multiple UL37 transcripts, including an unspliced
transcript, UL37 exon 1 (UL37x1), and ten alternatively
spliced UL37 transcripts (Adair et al., 2003, 2004, 2006;
Goldmacher et al., 1999; Kouzarides et al., 1988; Su et al.,
2003a, b; Tenney & Colberg-Poley, 1990, 1991a, b). The
UL37x1 anti-apoptotic protein (pUL37x1), also known as
viral mitochondrion-localized inhibitor of apoptosis or
vMIA, is the product of the predominant UL37x1 RNA
(Goldmacher et al., 1999; Kouzarides et al., 1988; Tenney &
Colberg-Poley, 1991a). pUL37x1 is essential for HCMV
growth in humans (Hayajneh et al., 2001) and for the
growth of primary HCMV strains (Jurak & Brune, 2006)
and HCMV strain AD169 (Dunn et al., 2003; Reboredo
et al., 2004; Sharon-Friling et al., 2006), but not of HCMV
strain TownevarATCC (McCormick et al., 2005) in
cultured fibroblasts.
Post-transcriptional RNA processing involves 59 capping,
splicing and 39 polyadenylation. Splicing of pre-mRNA
requires the assembly of spliceosomes that consist of five
small nuclear ribonucleoprotein particles (snRNPs) and
numerous non-snRNPs (Matlin & Moore, 2007; Wahl
et al., 2009). Serine/arginine-rich (SR) proteins play
roles in pre-spliceosome assembly, branchpoint entry and
snRNP interactions (Graveley, 2000; Shen et al., 2004).
Their activity is regulated by phosphorylation of serine
residues in the arginine/serine-rich domain by protein 3Present address: USAMRU-K, Unit 64109, APO, AE 09831, USA.
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activity, in turn, is regulated by subcellular partitioning and
anchoring in the cytoplasm (Ding et al., 2006). SRPK1
translocates from the cytoplasm to the nucleus in a cycle-
dependent manner before initiation of the M phase (Ding
et al., 2006). Cytoplasmic anchoring of SRPK1 results from
its interactions with two co-chaperones specific for heat-
shock proteins (Zhong et al., 2009). Osmotic stress can
also induce nuclear translocation of SRPK1 (Zhong et al.,
2009).
Polyadenylation requires recognition of a consensus
polyadenylation signal and a downstream cis element,
cleavage of the nascent transcript and addition of a poly(A)
tail to the 39 end of cleaved pre-mRNA (Moore &
Proudfoot, 2009; Proudfoot, 2004). Cleavage stimulation
factor (CstF) recognizes the downstream U- or G/U-rich
sequences through its CstF-64 subunit (MacDonald et al.,
1994; Takagaki et al., 1992; Wilusz et al., 1990).
UL37 RNA species share a common initiation site, but
UL37x1 RNA is unspliced and is polyadenylated at an
intronic site (Adair et al., 2003; Goldmacher et al., 1999;
Kouzarides et al., 1988; Su et al., 2003b; Tenney & Colberg-
Poley, 1991a, b). UL37x1 RNA becomes increasingly
predominant over its spliced isoforms during infection
(Adair et al., 2004). Alternative processing of UL37 RNAs is
dictated, in part, by the competition of cellular RNA
factors for its juxtaposed splicing and polyadenylation cis
elements (Su et al., 2003a). Similar competition was
subsequently found for cis elements in the HCMV major
immediate-early (MIE) transcripts, IE1 and IE2 (Sanchez
et al., 2004).
The UL37x1 unspliced transcript requires usage of a
cleavage site that contains a consensus polypyrimidine
tract-binding protein (PTB)-binding site, and its poly-
adenylation site usage is enhanced by a downstream
element, recognized by CstF-64 (Adair et al., 2004; Su
et al., 2003a). PTB strongly represses HCMV MIE gene
expression and replication (Cosme et al., 2009).
Temporal regulation of alternative UL37 RNA processing
during HCMV infection suggests that key post-transcrip-
tional processing factors are manipulated during infection.
HCMV infection increases the abundance of critical
cellular post-transcriptional processing factors, including
the SR protein ASF/SF2 (alternative splicing factor/splicing
factor 2), the essential polyadenylation factor CstF-64 and
the splicing suppressor PTB (Adair et al., 2003, 2004, 2006;
Su et al., 2003a).
Because SRPK1 is regulated primarily by subcellular
distribution (Ding et al., 2006) and HCMV immediate-
early (IE) RNA processing displays complex regulation, we
examined whether HCMV infection manipulates the
abundance and location of key cellular RNA-processing
factors. We found that the abundance of positive regulators
of splicing (SRPK1) and polyadenylation (CstF-64) were
increased during infection in the cytoplasm and nucleus,
respectively. Surprisingly, CstF-64 was partially included in
subnuclear viral replication compartments (VRCs). The
negative regulator of splicing, PTB, was partially relocalized
at early times of infection from the nucleus to cytoplasmic
punctate sites and then at late times to the nucleus, but was
selectively excluded from HCMV VRCs. Interestingly,
HCMV infection caused selective sorting of a nucleolar
component, fibrillarin, into cap structures at late times of
infection.
RESULTS
HCMV infection increases the abundance of
SRPK1
SRPK1, which phosphorylates SR proteins, is regulated by
its subcellular distribution rather than by affecting its
constitutive enzymic activity (Ding et al., 2006; Zhong
et al., 2009). Our previous data demonstrated that the
abundance of hypo-phosphorylated ASF/SF2 increases very
early during HCMV infection (Adair et al., 2004). We
therefore hypothesized that HCMV infection regulates the
subcellular distribution of SRPK1. To test this hypothesis,
we examined SRPK1 localization in human foreskin
fibroblasts (HFFs) in G0 phase (G0-HFFs) using confocal
imaging. At 12 h post-infection (p.i.), SRPK1 was localized
in the cytoplasm and nucleus of mock-treated and HCMV-
infected cells. However, nuclear speckles, some partially
co-localized with IE1/2, were more intense in HCMV-
infected than in mock-treated cells (Fig. 1a). Within 24
and 48 h p.i., SRPK1 progressively increased in abundance
in the cytoplasm of infected cells (Fig. 1b, c). The increase
in cytoplasmic SRPK1 continued through late times
(Fig. 1d, e). These results suggested that HCMV increases
the abundance of SRPK1, primarily in the cytoplasm of
infected cells.
SRPK1 abundance is increased in the cytoplasm
of HCMV-infected cells by late times of infection
To verify these results, we examined SRPK1 in nuclear
and cytoplasmic fractions from mock-infected and
HCMV-infected G0-HFFs (Fig. 2). The abundance of
SRPK1 increased progressively during HCMV infection.
At IE times of infection, the abundance of nuclear SRPK1
was transiently increased (~9.7-fold) more than cyto-
plasmic SRPK1 (~2.0-fold). By 48 and 72 h p.i., the
abundances of cytoplasmic SRPK1 (13.8-fold and 29.6-
fold, respectively) were progressively increased more than
nuclear SRPK1 (3.1-fold and 0.9-fold, respectively) at
the same times. The nuclear (lamin B) and cytoplasmic
[lactate dehydrogenase (LDH)] markers verified the
identity and purity of the fractions. The decrease in
lamin B at 72 h p.i. reflects its degradation during HCMV
nuclear egress (Marschall et al., 2005; Milbradt et al.,
2007, 2009). Taken together with the imaging results
above, we concluded that HCMV infection regulates the
C. E. Gaddy and others
1548 Journal of General Virology 91subcellular distribution of SRPK1, progressively increas-
ing its abundance in the cytoplasm of HCMV-infected
cells through to late times of infection.
To determine whether HCMV DNA replication or late
gene expression is required for the regulation of SRPK1
subcellular distribution, mock-infected or HCMV-infected
G0-HFFs were treated with phosphonoformate (PFA), an
inhibitor of HCMV DNA replication through oriLyt (a
cis-acting sequence that promotes initiation of lytic-phase
DNA replication), and examined by confocal microscopy
(Fig. 3). PFA treatment did not alter the SRPK1 subcellular
distribution or increased abundance in HCMV-infected
cells compared with untreated HCMV-infected cells. These
results indicated that the regulation of subcellular distri-
bution and abundance of SRPK1 does not require HCMV
DNA replication or late gene expression.
Divergent trafficking of PTB and CstF-64 in HCMV
infection
PTB and CstF-64 are known to affect the processing of
HCMV IE transcripts (Adair et al., 2004; Cosme et al.,
2009; Su et al., 2003a). PTB is a well-characterized
repressor of RNA splicing (Castelo-Branco et al., 2004).
CstF-64 plays a constitutive role in polyadenylation and its
abundance regulates the efficiency of 39 end processing (Qu
et al., 2007; Takagaki & Manley, 1998). Deletion of the
UL37x2 downstream element, predicted to bind CstF-64,
causes a large decrease in UL37x1 RNA polyadenylation
site usage (Adair et al., 2004; Su et al., 2003a).
To determine whether their subcellular distributions
were temporally and differentially regulated during
HCMV infection, we examined the co-localization of
PTB and CstF-64 in HCMV-infected G0-HFFs. At 12 h
Fig. 1. HCMV infection progressively increases the abundance of SRPK1 in the cytoplasm of infected G0-HFFs. G0-HFFs
were HCMV infected (m.o.i.53) or mock infected. At 12 (a), 24 (b), 48 (c), 72 (d) and 96 (e) h p.i., cells were harvested and
sequentially incubated with anti-SRPK1 (red, 1:1000) and mAb 810 (specific for MIE, green, 1:500), followed by the
corresponding secondary antibodies. Probed cells were imaged by confocal microscopy. Panels on the left and in the middle
show greyscale imaging, whereas panels on the right show the merged colour images.
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the nucleus, similarly to mock-treated cells, and their
co-localization at subnuclear sites was observed in some
HCMV-infected cells (Fig. 4a). By early times of infec-
tion (24 and 48 h p.i.), PTB was partially relocalized
to punctate bodies in the cytoplasm of some infected
cells (Fig. 4b, c). During late times of infection (72 and
96 h p.i.), the cytoplasmic PTB bodies were no longer
detected in HCMV-infected cells (Fig. 4d, e). In stark
contrast, CstF-64 continuously increased in the nucleus,
from IE through to late times of infection. CstF-64 was
included in subnuclear bodies that resembled HCMV
VRCs, whereas PTB was notably excluded from the same
subdomains.
To test whether PTB was excluded from HCMV VRCs,
HCMV-infected G0-HFFs were co-stained for PTB and
ppUL57 and examined by confocal microscopy (Fig. 4f).
ppUL57 is an HCMV-encoded, ssDNA-binding protein
and in these experiments served as a marker for VRCs, as
previous experiments have demonstrated the presence of
HCMV ppUL57 in VRCs at late times of infection (Penfold
& Mocarski, 1997). PTB was excluded from large sub-
nuclear compartments at 72 h p.i. and these were found to
be HCMV VRCs.
We determined the percentages of infected cells in which
PTB and CstF-64 were redistributed (Table 1). PTB did
not co-localize with ppUL57 in most of the cells (93.8%)
but partially co-localized with ppUL57 in a low
percentage (6.2%) of the infected cells. Conversely,
CstF-64 partially co-localized with ppUL57 in most
(97%) HCMV-infected cells and co-localized with
ppUL57 in only a few (3%) infected cells. These results
demonstrated the preponderance of PTB exclusion and
CstF-64 inclusion in HCMV VRCs, indicating the
probable importance of their subnuclear distribution for
HCMV replication.
To determine whether HCMV DNA replication and/or
late gene expression is required for PTB exclusion from
VRCs, we treated HCMV-infected cells with PFA and
examined the localization of PTB and CstF-64 at late
times of infection (Fig. 5). In contrast to the SRPK1
results in Fig. 3, PFA blocked the redistribution of PTB in
HCMV-infected cells. PTB distribution was dispersed
between the nucleus (76.4%) and cytoplasm (23.6%) of
PFA-treated, HCMV-infected cells at 96 h p.i. (Table 1).
These results established that HCMV DNA replication
and/or late gene expression is needed for PTB subnuclear
relocalization.
Fig. 2. Subcellular distribution of SRPK1 in
HCMV-infected G0-HFFs. HFFs (6.010
7
cells) were growth arrested and mock infected
or HCMV infected (m.o.i.53), harvested at the
indicated times, and fractionated into nuclear
and cytoplasmic fractions. Fractionated pro-
teins (20 mg) were resolved by electrophor-
esis, transferred to nitrocellulose and probed
with anti-SRPK1 (1:1000), anti-lamin B
(1:1000) and anti-LDH (1:1000). Probed
blots were stripped of bound antibodies after
exposure and reprobed with other antibodies.
The fold inductions in SRPK1 abundance were
determined by comparison of the densities of
the bands from HCMV-infected cells divided
by the densities of the corresponding mock-
infected cells.
Fig. 3. HCMV induction of cytoplasmic
SRPK1 during PFA treatment. G0-HFFs were
HCMV infected (m.o.i.510) and untreated or
treated with PFA (400 mgm l
”1), following
absorption, for 96 h p.i. Cells were harvested,
stained for MIE (green) and SRPK1 (red) and
visualized as in Fig. 1.
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nuclear and cytoplasmic levels of PTB and
CstF-64
To confirm their subcellular location observed by confocal
microscopy, we examined nuclear and cytoplasmic frac-
tions from HCMV-infected G0-HFFs for PTB and CstF-64
abundance (Fig. 6). At late times (48 and 72 h p.i.), full-
length cytoplasmic PTB was slightly increased (~2.3-fold),
whilst nuclear PTB was decreased (0.1-fold) at 72 h p.i. In
stark contrast, CstF-64 progressively increased in abun-
dance (2.6–40.9-fold), mostly in the nuclear compartment.
The nuclear (lamin B) and cytoplasmic (LDH) markers
verified the identity and purity of the fractions.
Fig. 4. Temporal relocalization of PTB and CstF-64 during HCMV infection. G0-HFFs were treated as in Fig. 1. HCMV-infected
and mock-infected cells were methanol fixed at 12 (a), 24 (b), 48 (c), 72 (d) and 96 (e) h p.i., and sequentially incubated with
anti-PTB (green, 1:250), anti-CstF-64 (red, 1:250) and mAb 810 (blue, 1:500; MIE) and then with the corresponding
secondary antibodies. Cells were imaged by confocal microscopy. The left and middle panels are greyscale, whilst the right
panel shows the merged images. (f) PTB is selectively excluded from HCMV VRCs at late times of infection. G0-HFFs were
HCMV infected (m.o.i.53) and fixed at 72 h p.i. as in Fig. 1 and sequentially incubated with anti-PTB (green, 1:250) and anti-
ppUL57 (blue, 1:250). Cells were then probed with secondary antibodies and imaged using a Zeiss Axiovert inverted UV
microscope with an ApoTome attachment. The left and middle panels show greyscale images whilst the right panels show an
overlay of both channels.
HCMV infection relocalizes RNA-processing factors
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component, fibrillarin, into nucleolar caps
The relocalization of nuclear components resembled
features of subnuclear redistribution during stress re-
sponses (Shav-Tal et al., 2005). HCMV infection modulates
some cellular stress responses by relocalization of cellular
proteins (Hakki et al., 2006). Nucleolar cap formation is
associated with transcriptional arrest and results from the
redistribution and sequestering of nucleolar and nucleo-
plasmic proteins into distinct bodies. We therefore
investigated whether HCMV reorganization of the nucleus
caused sorting of nucleolar components. PTB-associated
splicing factor (PSF) serves as a marker for dark nucleolar
caps (DNCs) in transcriptionally arrested cells (Dye &
Patton, 2001; Ghetti et al., 1992). We examined HCMV-
infected G0-HFFs at late times of infection (96 h p.i.) for
co-localization of PSF with ppUL57 (Fig. 7a). Similar to
PTB, PSF was partially excluded to the periphery of HCMV
VRCs.
Sorting of nucleolar components during RNA transcription
can result in the formation of fibrillarin-containing caps
that contain high concentrations of the nucleolar protein
fibrillarin (Shav-Tal et al., 2005). To determine whether
HCMV infection induces the formation of fibrillarin-
Table 1. PTB exclusion and CstF-64 inclusion in HCMV VRCs
Staining Subnuclear co-localization* Dispersed
Complete Partial None Nuclear Cytoplasmic
PTB and ppUL57
Mock infected 100% (264/264)
Mock+PFA 100% (312/312)
HCMV infected 0% (0/307) 6.2% (19/307) 93.8% (288/307)
HCMV+PFA 76.4% (370/484) 23.6% (114/484)
CstF-64 and ppUL57
Mock infected 100% (201/201)
Mock+PFA 100% (312/312)
HCMV infected 0% (0/298) 97.0% (289/298) 3.0% (9/298)
HCMV+PFA 100% (351/351)
*Co-localization of PTB or CstF-64 and ppUL57 (VRC marker) was measured in mock-infected or HCMV-infected G0-HFFs, either untreated or
PFA treated at 96 h p.i. as described in Fig. 5.
Fig. 5. PFA treatment blocks HCMV-induced redistribution of PTB at late times of infection. G0-HFFs were HCMV infected
(m.o.i.510) and untreated or PFA treated as in Fig. 3. Cells were harvested at 96 h p.i. and stained for PTB (green), CstF-64
(red) and ppUL57 (blue) and imaged by confocal microscopy as in Fig. 4.
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at late times of HCMV infection. We found that fibrillarin
was concentrated in cap structures, similar to light
nucleolar caps (LNCs) and closely apposed to nucleoli, in
the majority of HCMV-infected cells (78.9 vs 5.2% of
mock-infected HFFs) at late times of infection (96 h p.i.).
These studies indicated that HCMV infection causes
sorting of nucleolar components into fibrillarin-containing
caps in close proximity to VRCs.
To verify the imaging results above, we modified a protocol
used for subnuclear fractionation and examined HCMV-
infected cells at late times of infection (Fig. 7b). CstF-64,
SRPK1, fibrillarin, PSF and ppUL57 were enriched in the
subnuclear pelleted fraction at late times of infection,
whereas LDH was not. These results together with the
confocal microscopy results suggest that key RNA-pro-
cessing factors and selected nucleolar and nucleoplasmic
components are physically associated with subnuclear
compartments that contain HCMV VRC components.
DISCUSSION
HCMV infection temporally alters the abundance and
subcellular distribution of key post-transcriptional pro-
cessing factors during infection. At IE times, SRPK1, PTB
and CstF-64 co-localized in nuclear punctate sites with
the MIE proteins in HCMV-infected cells. IE1 and IE2,
visualized as single punctate foci, are enriched in sites
called nuclear domain 10 (ND10) at IE times (Ahn &
Hayward, 1997). Because IE1 becomes diffused in the
nucleus (Korioth et al., 1996) and IE2 remains at punctate
sites, the cellular RNA-processing factors appear to contain
IE2 at former ND10 sites. ND10s are active sites of HCMV
IE gene transcription (Ishov et al., 1997). The combined
presence of SRPK1, PTB and CstF-64 will predictably affect
alternative splicing and polyadenylation of HCMV IE
transcripts. Phosphorylation of SR proteins by SRPK1
targets them to sites of active transcription. PTB is known
to negatively regulate MIE pre-mRNA splicing (Cosme
et al., 2009), whereas CstF-64 selectively increases HCMV
UL37x1 poly(A) site usage (Adair et al., 2004; Su et al.,
2003a).
During the cell cycle, SRPK1 is translocated to the
nucleus during M phase (Ding et al., 2006). In contrast,
during HCMV infection, which causes pseudo-mitosis of
the infected cell (Hertel et al., 2007), SRPK1 is increased
mainly in the cytoplasm. Regulation of SRPK1 is achieved
by partitioning through an anchoring mechanism
(Ding et al., 2006) and by its interactions with molecular
co-chaperones (Zhong et al., 2009). Heat-shock protein
70, part of the macromolecular complex used to anchor
SRPK1 in the cytosol, is induced from IE to late times
of HCMV infection (Santomenna & Colberg-Poley,
1990) with kinetics similar to those we observed for
the progressively increasing abundance of cytoplasmic
SRPK1. HCMV infection is well documented to block
cellular stress pathways that would result in apoptosis
(Goldmacher et al., 1999; Reeves et al., 2007; Skaletskaya
et al., 2001; Terhune et al., 2007). Thus, HCMV infection
may effectively block the cellular stress responses that
could result in release of SRPK1 from the co-chaperone
complex and nuclear translocation. Of particular note,
HCMV infection redundantly blocks mitochondrial stress
responses (Goldmacher et al., 1999; Reeves et al., 2007),
possibly modulating oxidative stress, its consequent
release of SRPK1 from its co-chaperone complex and its
Fig. 6. Subcellular distribution of PTB and
CstF-64 in HCMV-infected G0-HFFs. G0-
HFFs were HCMV infected (m.o.i.53) or mock
infected, fractionated and blotted as in Fig. 2.
The same membranes were stripped and
reprobed with anti-PTB (1:250), rabbit anti-
CstF-64 (1:250), anti-lamin B (1:1000) and
anti-LDH (1:1000). Probed blots were
repeatedly stripped of bound primary and
secondary antibodies after exposure and
reprobed as required. The increases in PTB
and CstF-64 abundance were determined
using the density of the bands from HCMV-
infected cells divided by the density of the
corresponding mock-infected band,asin Fig.2.
Lighter exposures of the nuclear CstF-64 blot
were used for scanning and quantification.
HCMV infection relocalizes RNA-processing factors
http://vir.sgmjournals.org 1553Fig. 7. (a) HCMV infection induces the formation of fibrillarin-containing caps. G0-HFFs were mock infected or HCMV
infected and harvested at 96 h p.i. as in Fig. 3. Cells were stained with anti-fibrillarin (green, 1:250), anti-PSF (red, 1:250)
and anti-ppUL57 (blue, 1:250) antibodies and corresponding secondary antibodies. The left and middle panels are greyscale
and the rightmost panels show all three channels merged. The bottom panel shows an enlarged HCMV-infected cell. (b)
Co-sedimentation of cellular RNA-processing factors and nucleolar components with HCMV ppUL57, a VRC component.
G0-HFFs were mock infected (M) or HCMV infected (H, m.o.i.51) as in Fig. 2 and harvested at 96 h p.i. Cells were
fractionated into cytoplasmic fraction, subnuclear pellet and supernatant (Sup) by modification of the nucleolar isolation
procedure of Andersen et al. (2002). The cytoplasmic (Cyto) fraction was concentrated 5-fold and proteins (15 mg per well)
were resolved by SDS-PAGE and blotted as described in Fig. 2. The blots were reacted with antibodies against CstF-64
(1:2000), SRPK1 (1:1000), fibrillarin (1:1000), PSF (1:2000), ppUL57 (1:500) or LDH (1:1000). Probed blots were
stripped of bound primary and secondary antibodies after exposure and reprobed as required. The fold inductions in CstF-64,
SRPK1, fibrillarin and PSF abundance were determined by comparison of the densities of the bands from HCMV-infected
cells divided by the densities of the corresponding mock-infected cells as in Fig. 2 except where the mock- or HCMV-infected
band was not detectable (ND).
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et al., 2009).
The SRPK1 cytoplasmic location may allow continued
RNA splicing during HCMV infection but inhibit its
nuclear functions. HCMV virion egress requires the
destabilization of the nuclear lamina through recruitment
of the HCMV pUL97 by p32 and the structural modifica-
tions of HCMV proteins ppUL50 and ppUL53 through
their interaction with protein kinase C (Camozzi et al.,
2008; Marschall et al., 2005; Milbradt et al., 2007, 2009).
Phosphorylation of lamin B receptor (LBR) by SRPK1
induces its association with lamin B at the inner nuclear
membrane (Papoutsopoulou et al., 1999). SRPK1 phos-
phorylation of LBR also stimulates the binding of the
protein to chromatin and the stabilization of the nuclear
membrane (Takano et al., 2004). It is therefore possible
that continued anchoring of SRPK1 to the cytoplasm
sequesters its activity from the nucleus allowing efficient
egress of the HCMV nucleocapsids while allowing
continued RNA splicing to occur through late times of
infection.
As PTB inhibits splicing of the MIE transcripts and has
negative effects on HCMV growth (Cosme et al., 2009),
HCMV tightly regulates its subcellular distribution during
infection. During IE times of infection, PTB, CstF-64 and
MIE proteins are enriched in punctate structures, poten-
tially perinucleolar compartments (PNCs). PNCs are
subcellular structures, located at the periphery of nucleoli
with high concentrations of PTB (Ghetti et al., 1992;
Matera et al., 1995). PNCs are thought to be active sites of
RNA polymerase II and III transcription. At early times of
HCMV infection, PTB was partially translocated to discrete
cytoplasmic sites of some infected cells. As PTB was
relocalized, the nuclear PNCs in HCMV-infected cells
appeared to disintegrate. This dissolution of PNCs follow-
ing cytoplasmic PTB relocalization is consistent with the
requirement for localization of PTB at the periphery of the
nucleoli to maintain their integrity (Wang et al., 2003) and
may partially underlie the sorting of fibrillarin to nucleolar
caps.
By late times of infection, we observed exclusion of PTB
from increasingly prominent subnuclear structures and
the inclusion of CstF-64 in these. These proved to be
VRCs by co-localization with the HCMV DNA-binding
protein ppUL57. When HCMV DNA replication was
blocked, the formation of the VRCs and the redistribu-
tion PTB was reduced, suggesting a role for HCMV
DNA replication and/or late gene expression in PTB
exclusion.
The presence of CstF-64 and exclusion of PTB suggest that
HCMV VRCs are active sites of transcription and post-
transcriptional processing, in addition to sites of DNA
replication. RNA polymerase II, phosphorylated at Ser-2,
was found in HCMV VRCs at 48 h p.i. in HCMV-infected
G0-HFFs (Tamrakar et al., 2005). By subnuclear fractiona-
tion, we intriguingly found that HCMV ppUL57 mostly
co-sedimented with induced nuclear CstF-64 and SRPK1,
suggesting that these factors may be functionally associated
with HCMV VRCs during infection.
The abundance of CstF-64 is the rate-limiting factor for
the assembly of the core polyadenylation machineries, and
increases in CstF-64 abundance positively influence 39-
end processing and the use of weak polyadenylation sites.
Analysis of the HCMV UL37x1 polyadenylation signal,
contained within an intron, showed that this signal is
increasingly used during infection and that its usage is
enhanced by a downstream element (Adair et al.,2 0 0 4 ,
2006; Su et al., 2003a, b). The presence of CstF-64 at sites
of HCMV post-transcriptional processing could serve to
favour alternative polyadenylation of its transcripts,
despite increased levels of viral transcripts at late times
of infection.
The HCMV-induced sorting of nuclear components
included the redistribution of nucleolar components.
Sorting of nucleolar components in response to inhibition
of transcription results in the formation of dynamic
structure bodies (Shav-Tal et al., 2005). Fibrillarin is
normally localized in the dense fibrillar component
domain within nucleoli and segregates to LNCs following
actinomycin D treatment. We observed similar segregation
of fibrillarin to nucleolar caps at late times of HCMV
infection and in close proximity to VRCs. During
transcription inhibition, DNCs enriched in CstF-64 and
PSF are formed (Shav-Tal et al., 2005). Similar to stress-
responsive DNCs, HCMV VRCs include CstF-64 and do
not include PTB. However, in contrast to DNCs, HCMV
VRCs partially exclude PSF.
The question of what promotes nucleolar cap formation in
HCMV-infected cells remains unanswered. Several HCMV
proteins are known to localize to nucleoli (Salsman et al.,
2008). Sorting of nucleolar components into nucleolar caps
can result in the disintegration of PNCs (Shav-Tal et al.,
2005). PNCs disintegrate at early times of HCMV infection
when PTB shuttles to the cytoplasm and nuclear VRCs
begin to form.
Nucleolar cap formation has been attributed to transcrip-
tional arrest (Shav-Tal et al., 2005). Transcription of
cellular and viral genes continues to occur throughout the
HCMV life cycle. However, HCMV infection might
differentially inhibit transcription of sensor genes, resulting
in the formation of nucleolar caps. Alternatively, the
presence of HCMV proteins in nucleoli and Cajal bodies
(Salsman et al., 2008) may segregate nucleolar components
and cause formation of nucleolar caps. Finally, the addition
of pyruvate, whose concentration is markedly increased in
HCMV-infected cells (Munger et al., 2008), can lead to the
formation of nucleolar caps, as it does in other cell types
(Shav-Tal et al., 2005). Taken together, our studies show
that HCMV-induced restructuring of subnuclear domains
includes relocalization of cellular RNA-processing
machineries and nucleolar and nucleoplasmic components
during permissive infection.
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Cell culture. Primary HFFs were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) with 10% fetal calf serum (FCS;
HyClone/Gemini Bio-Products), penicillin/streptomycin (100 U ml
21
and 100 mgm l
21, respectively; Invitrogen) and growth arrested as
described previously (Santomenna & Colberg-Poley, 1990). Briefly,
HFFs were grown to confluence and fed very-low-serum medium
(0.2% FCS)for72 h.Conditionedmedium wasremoved fromthe cells
and saved for reapplication after appropriate treatments.
Virus infection. G0-HFFs were infected with HCMV (strain AD169)
grown in low-serum medium (2% FCS) at the indicated m.o.i.
Control cells were treated with mock-infected medium. Following
infection, in experiments to examine the requirement for HCMV
DNA synthesis and/or late gene expression, cells were treated with
PFA (400 mgm l
21; Sigma) for the duration of infection. Control cells
were untreated.
Preparation of nuclear and cytoplasmic fractions. Mock-treated
or HCMV-infected HFFs were harvested at various times p.i. by
trypsinization and collected by centrifugation. The cell pellets were
resuspended in ice-cold PBS, pelleted and immediately used or
quickly frozen and stored at 280 uC.
Nuclear and cytoplasmic fractions were prepared using a protocol
adapted from Scherl et al. (2002). Briefly, 10 vols hypotonic buffer
[10 mM Tris/HCl (pH 7.4), 10 mM NaCl, 1 mM MgCl2,1 m M
EDTA, 16 Protease Inhibitor Complete Cocktail (Roche), 1 mM
PMSF, 1 mM sodium orthovanadate and 50 mM NaF] were added to
cell pellets and incubated on ice for 1 h with occasional mixing.
Swollen cells were lysed by the addition of 0.3% Triton X-100
(Sigma) and dounce homogenization (25–30 strokes). Nuclei were
collected by centrifugation at 1000 g at 4 uC for 10 min. Supernatants
were removed from the pelleted nuclei, cleared from cellular debris by
centrifugation at 12879 g at 4 uC for 15 min, and stored for later use
as the cytoplasmic fraction.
Pelleted nuclei were resuspended in 0.25 M sucrose buffer containing
10 mM MgCl2 and isolated and pelleted by centrifugation (1200 g for
10 min) through a 0.88 M sucrose cushion containing 0.05 mM
MgCl2. Nuclei were resuspended in 0.25 M sucrose buffer and
collected by centrifugation (12879 g for 5 min). Nuclei were
resuspended in radioimmunoprecipitation assay (RIPA) buffer I
[50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1%
sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 16 Protease
Inhibitor Complete Cocktail, 1 mM PMSF, 1 mM sodium orthova-
nadate and 50 mM NaF] and incubated on ice for 15 min. To ensure
complete lysis, nuclei were sonicated briefly (10 s, power 250–275 W
cm
22, continuous pulse) and incubated on ice for an additional
15 min. Supernatants were subsequently cleared by centrifugation
(12879 g for 15 min at 4 uC). Cleared supernatants were used as the
nuclear fraction. Both the cytoplasmic and nuclear fractions were
stored at 220 uC (short term) or 280 uC (long term) until used.
Subnuclear fractions. Nuclei from HFFs infected with HCMV
(m.o.i.51) or mock-infected cells were fractionated by a nucleolar
isolation procedure (Andersen et al., 2002) with a minor modification
of the final recovery step. Briefly, RIPA buffer II was added to the
recovered fractions to final concentrations of 50 mM Tris/HCl
(pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate
and 16 Protease Inhibitor Complete Cocktail. The cytoplasmic and
nucleoplasmic fractions were then separated by centrifugation at
2800 g for 10 min at 4 uC, and the subnuclear fraction was sonicated
again five times for 10 s each. After centrifugation, the supernatant of
the cytoplasmic fraction was concentrated ~5-fold using an Ultra 4
UltraCel 3K centrifugal concentrator (Amicon).
Protein concentration. Protein concentrations were determined
using a BCA Protein Assay kit (Pierce) according to the manufac-
turer’s instructions. Absorbance measurements were quantified using
SoftMax Pro software (Molecular Devices).
Western blot analysis. Proteins (10–20 mg) were separated by
electrophoresis in NuPAGE Novex 10 or 12–14% polyacrylamide Bis/
Tris gels (Invitrogen) and transferred to Hybond ECL nitrocellulose
(GE Healthcare) membranes at 50 V for 1 h. Western blots were
blocked and reacted with the indicated antibodies as described
previously (Adair et al., 2004; Mavinakere et al., 2006). Briefly, blotted
proteins were incubated with primary antibodies diluted in PBS
with 1% BSA (Sigma) at room temperature for 1 h with gentle
shaking. Membranes were washed and probed with the correspond-
ing horseradish peroxidase (HRP)-conjugated secondary antibody
(diluted in PBS with 1% BSA) for 1 h at room temperature with
gentle shaking. Proteins were visualized by chemiluminescence by
briefly incubating the probed membranes in ECL Western Blotting
Substrate (Pierce) and exposing the reacted membranes to BioMax
MS film (Kodak) or HyBlot CL film (Denville Scientific). Images
from exposed film were digitized and formatted using ScanWizard
Pro v.7.0 (Microtek), a Bio-Rad GS-800 Calibrated Densitometer, and
Quantity One, Adobe Photoshop (v.7.0) and Microsoft PowerPoint
2003. When additional probing was required, membranes were
treated with stripping buffer [62.5 mM Tris/HCl (pH 6.4), 100 mM
2-mercaptoethanol, 2% SDS] for 1 h at 50 uC as described previously
(Mavinakere et al., 2006). Fold induction was determined by
comparison of the density of bands from infected cells with the
corresponding bands from mock-infected cells using Bio-Rad
Quantity One basic software.
Antibodies. The primary antibodies used for these studies at the
concentrations indicated in the figure legends were specific for CstF-
64 (Bethyl Laboratories), LDH (Millipore), lamin B (Santa Cruz),
SRPK1 (BD Transduction Laboratories), PTB C terminus (Zymed
Laboratories), fibrillarin (Abcam), PSF (Bethyl Laboratories), HCMV
IE1/IE2 (mAb 810; Chemicon) and HCMV ppUL57 (a gift from Dr
Lenore Pereira, University of California, CA, USA). Secondary
antibodies used in the immunofluorescence assays (IFAs) were
Alexa Fluor 488-conjugated goat anti-mouse IgG, Alexa Fluor 488-
conjugated goat anti-mouse IgG2a, Alexa Fluor 488-conjugated goat
anti-mouse IgG1, Alexa Fluor 568-conjugated goat anti-mouse IgG1,
Alexa Fluor 488-conjugated goat anti-mouse IgG2b, Alexa Fluor 647-
conjugated goat anti-mouse IgG2a and Alexa Fluor 568-conjugated
goat anti-rabbit IgG (Molecular Probes, Invitrogen). All Alexa Fluor
secondary antibodies were used at a 1:1500 dilution. Secondary
antibodies (1:2500) used for Western blots were HRP-conjugated
goat anti-mouse IgG (Stressgen Bioreagents), HRP-conjugated
donkey anti-goat IgG (Santa Cruz Biotechnology) and HRP-
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch, Santa
Cruz Biotechnology).
IFA. HFFs were seeded onto 18618 mm or 18 mm circular glass
coverslips (Fisher), allowed to reach confluence and serum starved as
described previously (Santomenna & Colberg-Poley, 1990). G0-HFFs
were mock infected or HCMV infected at the indicated multiplicities.
Mock-infected or HCMV-infected cells were fixed in ice-cold
methanol for 10 min. After fixation, cells were air dried and either
used immediately or stored at 4 uC until use. At the time of use, cells
were washed in PBS+0.05% Tween 20 (three 5 min washes),
followed by incubation with 10% normal goat serum (Jackson
ImmunoResearch) for 30 min at room temperature. Cells were then
washed with PBS+0.05% Tween 20 (three 5 min washes) and
incubated with primary antibody for 30 min at 37 uC. Double- and
triple-labelled cells were probed sequentially with primary antibodies
with washes (three 5 min washes) between incubation with each
antibody. Cells were then incubated simultaneously with secondary
C. E. Gaddy and others
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mounted onto microscope slides (Fisher) using ProLong Gold
antifade reagent (Molecular Probes, Invitrogen) and stored in the
dark at 4 uC until use.
Confocal laser-scanning microscopy. Probed cells were examined
by IFA using a Bio-Rad MRC 1024 confocal laser-scanning
microscope [Center for Microscopy and Image Analysis, George
Washington University (GWU) Washington, DC, USA] as described
previously (Bozidis et al., 2008; Colberg-Poley et al., 2000;
Mavinakere et al., 2006) or using a Zeiss LSM 510 confocal
microscope [Children’s Research Institute (CRI), Intellectual and
Developmental Disabilities Research Center, Washington, DC, USA].
Images were acquired by sequential excitation at 488, 561 and 633 nm
as appropriate using 406 (NA51.3), 636 (NA51.4) or 1006
[NA51.35 (GWU) or NA51.4 (CRI)] oil objectives. Post-acquisition
processing and image assembly were performed using ImageJ software
(National Institutes of Health, MD, USA), Zeiss ZEN 2008, Adobe
Photoshop (v.7.0) and Microsoft PowerPoint 2003.
ApoTome imaging. Images were acquired with a Zeiss Axiovert
inverted UV microscope with an ApoTome attachment following the
manufacturer’s instructions. Captured images were processed and
merged using the Zeiss Axiovision Image Analysis software (v. 4.6).
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